Screener
Sutro Biopharma STRO Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
Based on trailing twelve months.
The source filing: Sutro Biopharma’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224170
FAQ
- What is Sutro Biopharma's asset turnover?
- Sutro Biopharma (STRO) reported asset turnover of 0.4× in Q1 2026.
- How has Sutro Biopharma's asset turnover changed year-over-year?
- Sutro Biopharma's asset turnover increased by 92.9% year-over-year, from 0.2× to 0.4×.
- What is the long-term trend for Sutro Biopharma's asset turnover?
- Over 5 years (2020 to 2025), Sutro Biopharma's asset turnover has grown at a 18.7% compound annual growth rate (CAGR), from 0.2× to 0.4×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Sutro Biopharma's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude